- Beazley’s gross written premiums for the first nine months of 2025 reached $4.67 billion, marking a 1% increase compared to the previous year.
- The company’s cash and investments have grown by 2.5% year-over-year, totaling $11.72 billion.
- Beazley’s guidance for its undiscounted combined ratio has been upgraded to the low 80s, indicating improved operational efficiency.
- A significant investment of $500 million has been made to establish a new platform in Bermuda, focusing on expansion opportunities.
- Beazley anticipates its insurance written premium (IWP) growth for 2025 to remain flat or increase by low single digits.
- The company’s stock is viewed positively in the market, with 15 analysts offering buy recommendations and no holds or sells.
“`
A look at Beazley PLC Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Beazley PLC, a specialist insurance firm, is positioned for steady long-term growth based on its Smartkarma Smart Scores. With a solid Growth score of 4 and Resilience score of 4, Beazley is expected to expand steadily and weather challenges effectively. The company’s operations in Europe, the United States, and the Pacific region provide a diversified geographic presence, enhancing its growth prospects.
Although Beazley scores average on Value, Dividend, and Momentum with scores of 3, the company’s strong focus on growth and resilience indicates a promising future outlook. Investors looking for a stable investment in the insurance sector may find Beazley PLC a compelling choice given its positive long-term outlook and diversified insurance offerings.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
